HIV and AIDS and STI 2017 - 24: Test and Treat Policy for HIV Patients

⪻ On New Articles ⪼

‘Test and Treat Policy for HIV patients’ was launched in April 2017 providing treatment to all “people living with HIV (PLHIV) ” . PLHIV to be treated with Antiretro Viral Therapy regardless of CD4 count, clinical stage, age, or population. The National Strategic Plan for HIV and AIDS and STI 2017 - 24 was approved in June 2017.

Map of HIV Prevalence in India by District, 2005

Strategies of HIV/AIDS and STI 2017 - 24

National Strategic Plan for HIV and AIDS and STI 2017 - 24 includes:

  • Accelerating HIV prevention in key population and ‘at risk group’ .
  • Expanding quality assured HIV testing with universal access to comprehensive HIV care.
  • Elimination of mother to child transmission of HIV and syphilis.
  • Addressing the critical enablers in HIV programming
  • Restructuring the strategic information system to be efficient and patient-centric.

National Guidelines on HIV Counselling & Testing Services revised in Dec 2016 to include the HIV screening through trained ancillary health care provider in community based setting for priority population including High Risk Groups, TB suspect & patients, STI and RTI attendees, sexual partners and spouses of PLHIV, prison inmates, pregnant women, and adolescent age group

Current Statistics

  • Per HIV estimation 2015, India estimated to have 21 lakhs infected with HIV
  • 15.2 lakh PLHIV know their HIV status through the strategy of scaling up of HIV counseling & testing services.
  • 536 Anti-retroviral Therapy (ART) centers providing ART treatment

HIV in India

  • India has the third largest HIV epidemic in the world.
  • In 2015, HIV prevalence in India was 0.26 %- smaller than most other middle-income countries.
  • In 2005 68,000 people died from AIDS-related illnesses
  • India՚s HIV epidemic is slowing down, with 32 % decline in new HIV infections (86,000 in 2015) , 54 % decline in AIDS-related deaths between 2007 and 2015.3
  • HIV epidemic in India driven by heterosexual sex (87 % of new infections) .
  • Epidemic concentrated such as sex workers.
  • Manipur, Mizoram, Nagaland, Andhra Pradesh, and Karnataka have highest prevalence

Developed by: